| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/27/1997 | WO1997007118A1 Enediyne compounds |
| 02/27/1997 | WO1997007101A1 Radiation-activated cytotoxin therapy |
| 02/27/1997 | WO1997007097A1 Cyclopropylindoles and their seco precursors, and their use as prodrugs |
| 02/27/1997 | WO1997006827A1 Control of cd44 gene expression for therapeutic use |
| 02/27/1997 | WO1997006826A1 Gene therapy using ovine adenoviral vectors |
| 02/27/1997 | WO1997006805A1 Quinazolinone-containing pharmaceutical compositions for prevention of neovascularization and for treating human malignancies |
| 02/27/1997 | WO1997006796A1 Benzothiophene compounds |
| 02/27/1997 | WO1997006793A1 Non-steroidal sulfatase inhibitor compounds and their method of use |
| 02/27/1997 | WO1997006791A1 METHODS AND COMPOSITIONS USEFUL FOR INHIBITION OF αvβ5 MEDIATED ANGIOGENESIS |
| 02/27/1997 | WO1997006790A1 Carotenoid-nicotinamide-zinc compositions and methods of treatment using same |
| 02/27/1997 | WO1997003188A3 Use of mp52 or mp121 for treating and preventing diseases of the nervous system |
| 02/27/1997 | WO1997001579A3 Somatostatin peptides |
| 02/27/1997 | DE19531342A1 Verwendung von Aminoadamantan-Verbindungen als Immunregulatoren Use of aminoadamantane compounds as immune regulators |
| 02/27/1997 | DE19531067A1 Verwendung von Boswelliasäure und ihren Derivaten zur Hemmung der normalen und gesteigerten Leukozytenelastase- oder Plasminaktivität Use of boswellic acid and its derivatives for the inhibition of the normal and increased Leukozytenelastase- or plasmin |
| 02/27/1997 | CA2229554A1 Non-steroidal sulfatase inhibitor compounds and their method of use |
| 02/27/1997 | CA2229460A1 Radiation-activated cytotoxin therapy |
| 02/27/1997 | CA2229269A1 Enediyne compounds |
| 02/27/1997 | CA2229264A1 Cyclopropylindoles and their seco precursors, and their use as prodrugs |
| 02/27/1997 | CA2229208A1 Dna sequences and secreted proteins encoded thereby |
| 02/27/1997 | CA2229135A1 Carotenoid-nicotinamide-zinc compositions and methods of treatment using same |
| 02/27/1997 | CA2228965A1 Control of cd44 gene expression for therapeutic use |
| 02/27/1997 | CA2227174A1 Traf inhibitors |
| 02/26/1997 | EP0759442A1 Tumor immunotherapy using anti-idiotypic antibodies |
| 02/26/1997 | EP0759434A1 Benzothiophene compounds |
| 02/26/1997 | EP0759087A1 Compositions and methods for targeting gene delivery vehicles |
| 02/26/1997 | EP0759079A1 DNA ENCODING PRECURSOR OF INTERLEUKIN-1$g(b) CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE III (ICE rel?-III) |
| 02/26/1997 | EP0759075A1 Apoptosis regulating gene |
| 02/26/1997 | EP0759067A1 Transforming growth factor alpha h1 |
| 02/26/1997 | EP0759036A1 Immunointeractive molecules-i |
| 02/26/1997 | EP0759032A1 Isolated, mage-3 derived peptides which complex with hla-a2 molecules and uses thereof |
| 02/26/1997 | EP0759027A1 Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase |
| 02/26/1997 | EP0758892A1 Methods of use for peroxynitrite decomposition catalysts, pharmaceutical compositions therefor |
| 02/26/1997 | EP0758887A1 Multifunctional ligand for use as a diagnostic or therapeutic pharmaceutical |
| 02/26/1997 | EP0726911A4 Treatment of immunologic and hematologic disorders with igfbp alone or complexed with igf |
| 02/26/1997 | EP0690852B1 Method for purifying taxoids |
| 02/26/1997 | EP0519976B1 Neutrophil stimulating peptides |
| 02/26/1997 | CN1143969A Compositions and methods using unbound mpl receptor for stimulating platelet production |
| 02/26/1997 | CN1143907A Pharmaceutical compositions |
| 02/26/1997 | CN1143894A Macrophage inflammatory proteins-3,-4 and -1 r |
| 02/26/1997 | CN1143632A Fluorine-containing benzoylguanidines |
| 02/25/1997 | US5606083 Process for the preparation of taxane derivatives, new derivatives thus obtained and the compositions which contain them |
| 02/25/1997 | US5606032 Extraction of vertebrate brain material to obtain protein; chromatographic purification |
| 02/25/1997 | US5606017 Antitumor agents |
| 02/25/1997 | US5605938 Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate |
| 02/25/1997 | US5605930 Compositions and methods for treating and preventing pathologies including cancer |
| 02/25/1997 | US5605929 Methods and compositions for inhibiting 5α-reductase activity |
| 02/25/1997 | US5605927 Treatment of skin diseases using ginkgolide PAF antagonists |
| 02/25/1997 | US5605924 Sulfonate and carbamate derivatives of 3-aroylbenzo[b] thiophenes |
| 02/25/1997 | US5605905 Antitumoral compounds |
| 02/25/1997 | US5605825 Human PAK65 |
| 02/25/1997 | US5605808 Oncoprotein protein kinase |
| 02/25/1997 | US5605703 Liposomes encapsulating doxorubicin |
| 02/25/1997 | US5605700 Topical administration of toremifene and its metabolites |
| 02/25/1997 | US5605688 Recombinant dog and horse type I interferons |
| 02/25/1997 | CA2183937A1 Alkenyl-benzoylguanidine derivatives |
| 02/25/1997 | CA2127763C Alkaloids from mappia foetida, the use thereof and formulations containing them |
| 02/25/1997 | CA2078805C Cytokine preparation |
| 02/25/1997 | CA1338948C Composition for macrophage activation |
| 02/25/1997 | CA1338939C Vinylphenol derivatives, their preparation and their use |
| 02/25/1997 | CA1338937C Process for the manufacture of novel substituted alkanediphosphonic acids |
| 02/20/1997 | WO1997006253A1 Method of modulating gene expression with reduced immunostimulatory response |
| 02/20/1997 | WO1997006145A1 Fused indan derivatives and salts thereof |
| 02/20/1997 | WO1997006140A1 Acylated derivatives of melatonin and its analogues, useful as medicaments |
| 02/20/1997 | WO1997006138A1 4-mercaptopyrrolidine derivatives as farnesyl transferase inhibitors |
| 02/20/1997 | WO1997005873A2 Use of fluconazole for inhibiting the growth of cancers |
| 02/20/1997 | WO1997005872A2 Use of 1h-1,2,4-triazole derivatives for inhibiting the growth of cancers |
| 02/20/1997 | WO1997005870A2 Use of griseofulvin for inhibiting the growth of cancers |
| 02/20/1997 | WO1997005859A2 Use of alicyclic diamines as immunomodulators |
| 02/20/1997 | WO1996040757A3 Lhrh antagonist peptides |
| 02/20/1997 | WO1996040260A3 Immunotoxins specific for cd80 and cd86 expressing cells |
| 02/20/1997 | CA2229024A1 Use of fluconazole for inhibiting the growth of cancers |
| 02/20/1997 | CA2228689A1 Use of alicyclic diamines as immunomodulators |
| 02/20/1997 | CA2228503A1 Use of griseofulvin for inhibiting the growth of cancers |
| 02/20/1997 | CA2228502A1 Use of 1h-1,2,4-triazole derivatives for inhibiting the growth of cancers |
| 02/19/1997 | EP0758681A2 Inhibiting transformation of cells having elevated purine metabolic enzyme activity |
| 02/19/1997 | EP0758644A1 Sulfonyl- or sulfinyl-benzoyl-guanidine derivatives |
| 02/19/1997 | EP0758452A1 Modulators of cytokines of the tgf-beta superfamily and methods for assaying for same |
| 02/19/1997 | EP0758394A1 Bifunctional protein, preparation and use |
| 02/19/1997 | EP0758390A1 Angiostatin and method of use for inhibition of angiogenesis |
| 02/19/1997 | EP0758387A1 Thymidine kinase mutants |
| 02/19/1997 | EP0758382A1 Enhancing the sensitivity of tumor cells to therapies |
| 02/19/1997 | EP0758342A1 New peptide active substance and production thereof |
| 02/19/1997 | EP0758335A1 Preparation of a camptothecin derivative by intramolecular cyclisation |
| 02/19/1997 | EP0758333A1 Intermediates in pharmaceutical camptothecin preparation |
| 02/19/1997 | EP0758331A1 Polyethylene glycol derivatised dihydro or tetrahydro porphyrins, their preparation and their use as tumour localising, photosensitising compounds |
| 02/19/1997 | EP0758328A1 Anti-cancer compounds containing cyclopentaquinazoline ring |
| 02/19/1997 | EP0758312A1 Substituted fused and bridged bicyclic compounds as therapeutic agents |
| 02/19/1997 | EP0758252A1 TIN-117m-CONTAINING RADIOTHERAPEUTIC AGENTS |
| 02/19/1997 | EP0758250A1 Texaphyrin solid-supports and devices |
| 02/19/1997 | EP0758247A1 O-desulfated heparin derivatives, methods of making and uses thereof |
| 02/19/1997 | EP0758243A1 BINDING OF E-SELECTIN, P-SELECTIN OR L-SELECTIN TO SIALYL-LEWISx OR SIALYL-LEWISa |
| 02/19/1997 | EP0758232A1 Methods for modulating t cell responses by manipulating intracellular signal transduction |
| 02/19/1997 | EP0758231A1 Taxane class derivative based pharmaceutical compositions |
| 02/19/1997 | CN1143386A Transforming growth factor alpha-H1 |
| 02/19/1997 | CN1143374A Non-viral vector |
| 02/19/1997 | CN1143372A Haemopoietic manuration factor |
| 02/19/1997 | CN1143366A 4-amino derivatives of mycophenolic acid |
| 02/19/1997 | CN1143363A Isoxazoline compounds as inhibitors of TNF release |
| 02/19/1997 | CN1143358A Benzamide analogs, useful as parp (ADP-ribosyltransferase, ADRPT) DNA repair enzyme inhibitors |
| 02/19/1997 | CN1143325A Method for selective methionine starvation of malignant cells in mammals |